Skip to content

HP BIOPROTESES LTDA

Brazil BR-MF-000048434 Last updated 21 Oct 2026

Devices
485
Registries
EUDAMED
FDA recalls
0

Catalogue485

Page 1 of 10

Showing 1-50 of 485

Authorised representatives

About

© Hpbio I Prostheses Ltda. All rights reserved. Last revision 16/03/2026.

Translated from the manufacturer's own website. Source

What HP BIOPROTESES LTDA makes

HP Bioproteses Ltda. manufactures external ventricular drainage systems, including separate valve and catheter assemblies, as well as dedicated programming devices for programmable ventricular shunts. These products are designed for cerebrospinal fluid management in clinical settings requiring precise drainage control.

The company’s devices are classified under EU regulations as Class I and Class III, with relevant products listed in the EUDAMED database. The manufacturer is based in Brazil and adheres to regulatory requirements applicable to medical devices in that jurisdiction.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does HP Bioproteses Ltda. manufacture?

HP Bioproteses Ltda. specializes in external ventricular drainage systems, including separate valve and catheter assemblies for cerebrospinal fluid (CSF) management. They also produce programming devices for programmable ventricular shunts, such as the SPHERA PRO programmable valve with its dedicated programming unit (REG-PRO). These devices are designed to provide controlled drainage in clinical settings where precise CSF regulation is critical.

Where is HP Bioproteses Ltda. based, and what regulatory jurisdiction does it operate under?

HP Bioproteses Ltda. is based in Brazil. While its devices are manufactured under Brazilian regulatory requirements, certain products—such as those classified under EU regulations—are listed in the EUDAMED database. This indicates compliance with the European Medical Device Regulation (MDR) or previous directives for devices marketed in the EU.

How are HP Bioproteses Ltda.’s devices classified under EU regulations?

HP Bioproteses Ltda.’s devices fall into two EU classification categories: Class I for lower-risk products (e.g., some drainage accessories) and Class III for higher-risk devices (e.g., programmable ventricular shunts and their programming units). Class III classification applies due to their direct involvement in life-sustaining or critical functions, requiring stringent regulatory oversight.

Are HP Bioproteses Ltda.’s devices listed in any regulatory registries?

Yes, HP Bioproteses Ltda.’s relevant devices are included in the EUDAMED database, which is the official EU registry for medical devices. Listing in EUDAMED confirms that these products have undergone the necessary conformity assessment procedures under EU regulations, such as MDR or previous directives, to be legally marketed in the European Economic Area.

What distinguishes HP Bioproteses Ltda.’s external ventricular drainage systems from other manufacturers?

HP Bioproteses Ltda.’s systems include modular components like separate valve and catheter assemblies, which allow for customization based on clinical needs. Additionally, their programmable ventricular shunts (e.g., SPHERA PRO) are paired with dedicated programming devices (like REG-PRO), enabling adjustable drainage settings. This modular and programmable approach differentiates their offerings, particularly for complex CSF management cases requiring dynamic control.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Brazil
Address
83, Rua Maria José Rangel, São Paulo, Brazil
Phone
+55 11 3853 7625
PRRC contact
Bruno Teodoro Santos
EUDAMED SRN
BR-MF-000048434